Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Melero Moreno

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 10, 2019
Economic analysis of biological therapies for severe asthma treatmentCarlos Almonacid-Sánchez, Carlos Melero-Moreno
Archivos De Bronconeumologia|April 1, 2010
[Asthma in the Archivos de Bronconeumología: a review of publications in the year 2009]Carlos Melero-Moreno, Antolín López-Viña, Vicente Plaza
Journal of Asthma and Allergy|May 2, 2022
COVID-19 and Severe Asthma: Reflections and Future Solutions [Letter]Javier Domínguez-Ortega, Silvia Sánchez-García, Carlos Melero Moreno
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 14, 2018
Economic impact of severe asthma in Spain: multicentre observational longitudinal studyCarlos Melero Moreno, Santiago Quirce, Alicia Huerta, et al.
Archivos De Bronconeumologia|February 9, 2011
[Advances in asthma: review of publications in Archivos de Bronconeumología in the last year]Isabel Urrutia Landa, Carolina Cisneros Serrano, Carlos Melero-Moreno, et al.
Open Respiratory Archives|July 27, 2023
Mepolizumab and COPD in Real LifeFernando Revuelta-Salgado, Rocío Magdalena Díaz-Campos, Ascensión Hernando-Sanz, et al.
Frontiers in Allergy|January 27, 2023
Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approachAntolín López-Viña, Rocio M Diaz Campos, Andrea Trisan Alonso, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 16, 2016
Asthmatic granulomatosis: A new presentation or a new asthma phenotype?Rocío M Díaz Campos, Irina Bobolea, María Emilia Banderas Montalvo, et al.
Frontiers in Allergy|December 1, 2022
Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approachAntolín López-Viña, Rocío M Díaz Campos, Andrea Trisan Alonso, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 4, 2016
Measuring total IgE is useful in detecting exacerbations in patients with allergic bronchopulmonary aspergillosis receiving omalizumabIrina Bobolea, Consuelo Fernández Rodriguez, Rocio Diaz-Campos, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|November 10, 2019
Economic analysis of biological therapies for severe asthma treatmentCarlos Almonacid-Sánchez, Carlos Melero-Moreno
Archivos De Bronconeumologia|April 1, 2010
[Asthma in the Archivos de Bronconeumología: a review of publications in the year 2009]Carlos Melero-Moreno, Antolín López-Viña, Vicente Plaza
Journal of Asthma and Allergy|May 2, 2022
COVID-19 and Severe Asthma: Reflections and Future Solutions [Letter]Javier Domínguez-Ortega, Silvia Sánchez-García, Carlos Melero Moreno
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 14, 2018
Economic impact of severe asthma in Spain: multicentre observational longitudinal studyCarlos Melero Moreno, Santiago Quirce, Alicia Huerta, et al.
Archivos De Bronconeumologia|February 9, 2011
[Advances in asthma: review of publications in Archivos de Bronconeumología in the last year]Isabel Urrutia Landa, Carolina Cisneros Serrano, Carlos Melero-Moreno, et al.
Open Respiratory Archives|July 27, 2023
Mepolizumab and COPD in Real LifeFernando Revuelta-Salgado, Rocío Magdalena Díaz-Campos, Ascensión Hernando-Sanz, et al.
Frontiers in Allergy|January 27, 2023
Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approachAntolín López-Viña, Rocio M Diaz Campos, Andrea Trisan Alonso, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 16, 2016
Asthmatic granulomatosis: A new presentation or a new asthma phenotype?Rocío M Díaz Campos, Irina Bobolea, María Emilia Banderas Montalvo, et al.
Frontiers in Allergy|December 1, 2022
Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approachAntolín López-Viña, Rocío M Díaz Campos, Andrea Trisan Alonso, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 4, 2016
Measuring total IgE is useful in detecting exacerbations in patients with allergic bronchopulmonary aspergillosis receiving omalizumabIrina Bobolea, Consuelo Fernández Rodriguez, Rocio Diaz-Campos, et al.
Pageof 3